Alaunos Therapeutics is a preclinical-stage biopharmaceutical company focused on developing novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders. The company aims to create non-hormonal treatments for conditions such as metabolic dysfunction-associated steatotic liver disease.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.